NO20063958L - HIV integrase inhibitorer - Google Patents

HIV integrase inhibitorer

Info

Publication number
NO20063958L
NO20063958L NO20063958A NO20063958A NO20063958L NO 20063958 L NO20063958 L NO 20063958L NO 20063958 A NO20063958 A NO 20063958A NO 20063958 A NO20063958 A NO 20063958A NO 20063958 L NO20063958 L NO 20063958L
Authority
NO
Norway
Prior art keywords
integrase inhibitors
hiv integrase
hiv
treatment
aids
Prior art date
Application number
NO20063958A
Other languages
English (en)
Inventor
Eric Eugene Boros
Ronald George Sherrill
Brian A Johns
Cecilia Koble
Takashi Kawasuji
Noriyuki Kurose
Hitoshi Mural
Jason Gordon Weatherhead
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20063958L publication Critical patent/NO20063958L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Foreliggende oppfinnelse omfatter forbindelser som er HIV integrase inhibitorer og som derfor er anvendelige ved hemning av HIV replikasjon, forebygging og/eller behandling av infeksjon ved HIV og ved behandling av AIDS og/eller ARC.
NO20063958A 2004-02-11 2006-09-05 HIV integrase inhibitorer NO20063958L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54367004P 2004-02-11 2004-02-11
PCT/US2005/004085 WO2005077050A2 (en) 2004-02-11 2005-02-10 Hiv integrase inhibitors

Publications (1)

Publication Number Publication Date
NO20063958L true NO20063958L (no) 2006-09-22

Family

ID=34860447

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063958A NO20063958L (no) 2004-02-11 2006-09-05 HIV integrase inhibitorer

Country Status (15)

Country Link
US (3) US8691991B2 (no)
EP (1) EP1720856B1 (no)
JP (1) JP4859676B2 (no)
KR (1) KR20070002006A (no)
CN (1) CN1976915A (no)
AU (1) AU2005211733A1 (no)
BR (1) BRPI0507628A (no)
CA (1) CA2555176A1 (no)
ES (1) ES2433477T3 (no)
IL (1) IL177189A0 (no)
MA (1) MA28358A1 (no)
MX (1) MXPA06009132A (no)
NO (1) NO20063958L (no)
RU (1) RU2006128848A (no)
WO (1) WO2005077050A2 (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1720856B1 (en) 2004-02-11 2013-08-14 GlaxoSmithKline LLC Hiv integrase inhibitors
PT1874117E (pt) 2005-04-28 2013-10-17 Shionogi & Co Derivado policíclico de carbamoílpiridona possuindo actividade inibidora de hiv-integrasse
EP1910363A4 (en) * 2005-08-04 2010-05-26 Glaxosmithkline Llc INHIBITORS OF HIV INTEGRASE
WO2007019130A2 (en) * 2005-08-04 2007-02-15 Smithkline Beecham Corporation Hiv integrase inhibitors
JP2009503083A (ja) * 2005-08-04 2009-01-29 スミスクライン ビーチャム コーポレーション Ｈｉｖインテグラーゼ阻害薬
US20080194523A1 (en) * 2005-08-04 2008-08-14 Smithkline Beecham Corporation Hiv Integrase Inhibitors
AR059733A1 (es) * 2006-03-07 2008-04-23 Smithkline Beecham Corp Compuesto derivado de glicina n- sustituida con heteroaromaticos bicicicos, composicion farmaceutica que lo comprende, uso para preparar un medicamento para tratar la anemia y proceso para su preparacion
MX2008014908A (es) 2006-05-26 2009-05-13 Toyama Chemical Co Ltd Compuesto heterociclico nuevo o sal del mismo e intermedio del mismo.
EP1956016A1 (en) * 2006-12-15 2008-08-13 Bayer Schering Pharma Aktiengesellschaft Bicyclic acyltryptophanols
EP2111399A2 (en) 2006-12-18 2009-10-28 Amgen Inc. Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
ES2393326T3 (es) 2006-12-18 2012-12-20 Amgen, Inc Compuestos basados en azaquinolona que presentan actividad inhibidora de prolil hidroxilasas, composiciones y usos de los mismos
ES2446418T3 (es) 2007-04-18 2014-03-07 Amgen, Inc Derivados de indanona que inhiben la prolil hidroxilasa
EP2142509B1 (en) 2007-04-18 2013-12-04 Amgen, Inc Quinolones and azaquinolones that inhibit prolyl hydroxylase
AU2008241503A1 (en) * 2007-04-18 2008-10-30 Merck Sharp & Dohme Corp. Novel 1,8-naphthyridine compounds
WO2008137084A2 (en) 2007-05-04 2008-11-13 Amgen Inc. Diazaquinolones that inhibit prolyl hydroxylase activity
US8030346B2 (en) 2007-05-04 2011-10-04 Amgen Inc. Heterocyclic quinolone derivatives that inhibit prolyl hydroxylase activity
WO2010011818A1 (en) * 2008-07-25 2010-01-28 Smithkline Beecham Corporation Chemical compounds
WO2010011819A1 (en) * 2008-07-25 2010-01-28 Smithkline Beecham Corporation Chemical compounds
US8283366B2 (en) 2010-01-22 2012-10-09 Ambrilia Biopharma, Inc. Derivatives of pyridoxine for inhibiting HIV integrase
UA105556C2 (uk) * 2010-01-27 2014-05-26 Віів Гелскер Компані Комбінація сполук, що містить інгібітори віл інтегрази з іншими терапевтичними агентами
US20110223131A1 (en) * 2010-02-24 2011-09-15 Gilead Sciences, Inc. Antiviral compounds
NZ603332A (en) 2010-04-02 2014-11-28 Senomyx Inc Sweet flavor modifier
KR20130065728A (ko) 2010-10-14 2013-06-19 임뮤나르 에이비 Ahr 활성화제로서의 1,2-디히드로-4-히드록시-2-옥소-퀴놀린-3-카르복사닐리드
CA2819889C (en) 2010-12-06 2020-12-15 Confluence Life Sciences, Inc. Substituted pyridinone-pyridinyl compounds
US9359300B2 (en) 2010-12-06 2016-06-07 Confluence Life Sciences, Inc. Methyl/difluorophenyl-methoxy substituted pyridinone-pyridinyl compounds, methyl-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds, and methyl-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds
WO2012147763A1 (ja) 2011-04-26 2012-11-01 塩野義製薬株式会社 オキサジン誘導体およびそれを含有するｂａｃｅ１阻害剤
EP2742026B1 (en) 2011-08-12 2016-10-05 Senomyx, Inc. Sweet flavor modifier
CA2893843C (en) 2012-12-21 2018-09-04 Gilead Sciences, Inc. Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
CA2917344C (en) 2013-06-07 2021-09-07 Confluence Life Sciences, Inc. Methyl/fluoro-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds and fluoro-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds
US11339128B2 (en) 2014-11-07 2022-05-24 Firmenich Incorporated Substituted 4-amino-5-(cyclohexyloxy)quinoline-3-carboxylic acids as sweet flavor modifiers
CN105348282B (zh) * 2015-12-02 2018-06-29 北京工业大学 一种hiv-1整合酶抑制剂化合物及其制备方法和应用
BR112022019349A2 (pt) 2020-03-27 2022-11-16 Aclaris Therapeutics Inc Forma cristalina, composição farmacêutica, comprimido e método para isolar um composto
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1532802A (en) 2000-10-12 2002-04-22 Merck & Co Inc Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors
DE60124577T2 (de) 2000-10-12 2007-09-27 Merck & Co., Inc. Aza- und polyaza-naphthalenylcarbonsäureamide als hiv-integrase-hemmer
WO2002036734A2 (en) 2000-10-12 2002-05-10 Merck & Co., Inc. Aza-and polyaza-naphthalenyl ketones useful as hiv integrase inhibitors
ATE430745T1 (de) 2000-10-12 2009-05-15 Merck & Co Inc Aza- und polyaza naphthalenyl karboxamide als inhibitoren der hiv-integrase
IL157638A0 (en) 2001-03-01 2004-03-28 Shionogi & Co Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity
ES2291642T3 (es) * 2002-01-17 2008-03-01 MERCK & CO., INC. Hidroxinaftiridinoncarboxamidas utiles como inhibidores de la integrasa de vih.
DE60322920D1 (de) 2002-08-13 2008-09-25 Shionogi & Co Heterocyclische verbindungen mit hiv-integrase-hemmender wirkung
EP1545538A2 (en) 2002-08-29 2005-06-29 Merck & Co., Inc. N-biarylmethyl aminocycloalkanecarboxamide derivatives
TW200505902A (en) * 2003-03-20 2005-02-16 Schering Corp Cannabinoid receptor ligands
WO2005023189A2 (en) 2003-09-03 2005-03-17 Pharmacia Corporation Method of cox-2 selective inhibitor and nitric oxide-donating agent
WO2005028478A1 (en) 2003-09-19 2005-03-31 Gilead Sciences, Inc. Aza-quinolinol phosphonate integrase inhibitor compounds
EP1720856B1 (en) 2004-02-11 2013-08-14 GlaxoSmithKline LLC Hiv integrase inhibitors

Also Published As

Publication number Publication date
WO2005077050A3 (en) 2006-11-23
EP1720856A4 (en) 2009-11-11
JP2007523086A (ja) 2007-08-16
JP4859676B2 (ja) 2012-01-25
AU2005211733A1 (en) 2005-08-25
KR20070002006A (ko) 2007-01-04
EP1720856B1 (en) 2013-08-14
ES2433477T3 (es) 2013-12-11
BRPI0507628A (pt) 2007-07-03
US20140256713A1 (en) 2014-09-11
CN1976915A (zh) 2007-06-06
MA28358A1 (fr) 2006-12-01
CA2555176A1 (en) 2005-08-25
US20150225399A1 (en) 2015-08-13
EP1720856A2 (en) 2006-11-15
WO2005077050A2 (en) 2005-08-25
US8691991B2 (en) 2014-04-08
IL177189A0 (en) 2006-12-10
US20070124152A1 (en) 2007-05-31
RU2006128848A (ru) 2008-03-20
MXPA06009132A (es) 2007-03-26

Similar Documents

Publication Publication Date Title
WO2005077050A3 (en) Hiv integrase inhibitors
CY1126771T1 (el) Συνδυασμοι δολουτεγραβιρης και λαμιβουδινης για την αγωγη λοιμωξης απο hiv
WO2005115398A3 (en) Hiv integrase inhibitors
CY1114981T1 (el) Προφαρμακα ντολουτεγκραβιρης
TW200738728A (en) HIV integrase inhibitors
NO20064547L (no) Fremgangsmater for behandling av HIV infeksjon
WO2007044565A3 (en) Composition and synthesis of new reagents for inhibition of hiv replication
WO2008002959A3 (en) Hiv integrase inhibitors
UA89220C2 (ru) Способ лечения вич/спида путем приема без пищи или в условиях голодания твердого фармацевтического дозированного состава ингибитора вич-протеазы
WO2004004657A3 (en) Hiv integrase inhibitors
WO2004096128A3 (en) Hiv integrase inhibitors
NO20073105L (no) Pyridazinonforbindelser
MX2009006535A (es) Derivados de indol-4-il-pirimidinil-2-il-amina y su uso como inhibidores de cinasa dependiente de ciclina.
NO20082135L (no) HIV integrase inhibitorer
NO20091955L (no) Antivirale sammensetninger, og fremgangsmater for anvendelse
NO20084749L (no) Organiske forbindelser og deres anvendelser
NO20083333L (no) Fremgangsmater for forbedring av farmakokinetikken til HIV-integraseinhibitorer
WO2008118849A3 (en) Hiv-1 protease inhibitors
NO20090322L (no) 6-(heterosykel-substituert benzyl)-4-oksoquinolin forbindelse samt anvendelse av det samme som IIIV integrave inhibitor
NO20065075L (no) Ikke-nukleosidbaserte revers-transkriptase-inhibitorer.
CR20110184A (es) Inhibidores de la integrasa del vih
WO2007019098A3 (en) Hiv integrase inhibitors
WO2007059125A3 (en) Hiv integrase inhibitors
WO2006081554A3 (en) Phenyl-substituted pyrrolidones
WO2020055858A8 (en) Pyridopyrazine and pyridotriazine inhibitors of influenza virus replication

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application